Clinical trial
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in…
NCT00324727 · Delcath Systems Inc., Industry · Completed
Key facts
| NCT number | NCT00324727 |
|---|---|
| Title | Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma |
| Official title | A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver |
| Lead sponsor | Delcath Systems Inc., Industry |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | melphalan, regional chemotherapy, systemic chemotherapy, hepatic artery embolization |
| Enrollment | 93 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | May 11, 2006 |
| Last update posted | Jun 21, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: